pyrroles has been researched along with Ureteral Obstruction in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| El-Kashef, DH; Makled, MN | 1 |
| Ji, X; Li, J; Liu, Y; Tan, R; Wang, H; Wang, L; Wu, Z; Zhang, Y; Zhong, X; Zhu, M | 1 |
| Huang, XR; Lan, HY; Meng, XM; Zhang, Y | 1 |
| Bayliss, G; Guan, Y; Liu, L; Masucci, MV; Xiong, C; Zhang, W; Zhang, Y; Zhao, TC; Zhou, X; Zhuang, MA; Zhuang, S | 1 |
| Arévalo, M; Docherty, NG; Eleno, N; Fuentes-Calvo, I; Grande, MT; López-Novoa, JM; Pérez-Barriocanal, F; Rodríguez-Peña, AB | 1 |
| Mitch, WE; Wang, Y; Yan, J; Yang, J; Zhang, Z | 1 |
| Chou, SY; Fitzgerald, JP; Franco, I; Gulmi, FA; Kim, H; Mooppan, UM; Saini, R | 1 |
| Chou, SY; Gulmi, FA; Kamdar, C; Kim, H; Mooppan, UM | 1 |
| Chuang, WL; Chuang, YH; Huang, CH; Huang, SP; Liu, CK | 1 |
| Fujita, Y; Imai, E; Ito, Y; Kinashi, H; Maruyama, S; Matsui, K; Matsuo, S; Mizuno, M; Mizuno, T; Noda, Y; Sawai, A; Shimizu, H; Suzuki, Y; Takei, Y | 1 |
| Andrade, L; Danilovic, A; Dénes, FT; Lopes, RI; Oshiro, FM; Sanches, TR; Seguro, AC; Shimizu, MH | 1 |
| Asano, T; Hayakawa, M; Kosaka, T; Miyajima, A; Mizuguchi, Y | 1 |
| Chou, SY; Gulmi, FA; Kim, H; Michli, E; Mooppan, UM | 1 |
| Chen, M; Liu, B; Ou, ST; Peng, HX; Zhang, C | 1 |
| Kasper, KA; Kuzel, TM; Meeks, JJ; Smith, ND; Yang, X | 1 |
| Englert, H; Klaus, E; Zwergel, T; Zwergel, U | 1 |
16 other study(ies) available for pyrroles and Ureteral Obstruction
| Article | Year |
|---|---|
Saroglitazar attenuates renal fibrosis induced by unilateral ureteral obstruction via inhibiting TGF-β/Smad signaling pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Fibrosis; Inflammation; Kidney Diseases; Male; Oxidative Stress; Phenylpropionates; PPAR alpha; PPAR gamma; Pyrroles; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2020 |
Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling.
Topics: Animals; Apoptosis; Fibrosis; Inflammation; Isoquinolines; Kidney; Male; Mice, Inbred BALB C; Myofibroblasts; Pyridines; Pyrroles; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2018 |
The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fibrosis; Isoquinolines; Kidney; Male; Mice, Inbred C57BL; Pyridines; Pyrroles; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta; Ureteral Obstruction | 2018 |
Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.
Topics: Animals; Bone Morphogenetic Protein 7; Cell Line, Transformed; Fibrosis; Histone Deacetylase Inhibitors; Histone Deacetylases; Hydroxamic Acids; Kidney Diseases; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Pyrroles; Smad7 Protein; Transforming Growth Factor beta1; Ureteral Obstruction | 2019 |
Effect of angiotensin II and small GTPase Ras signaling pathway inhibition on early renal changes in a murine model of obstructive nephropathy.
Topics: Angiotensin II; Animals; Atorvastatin; Disease Models, Animal; Fibrosis; Heptanoic Acids; Humans; Kidney; Kidney Diseases; Mice; Monomeric GTP-Binding Proteins; Pyrroles; Receptor, Angiotensin, Type 1; Signal Transduction; Ureteral Obstruction | 2014 |
JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Topics: Actins; Animals; Apoptosis; Bone Marrow Transplantation; Cells, Cultured; Collagen Type I; Extracellular Matrix Proteins; Fibroblasts; Fibronectins; Fibrosis; Interleukin-13; Interleukin-4; Janus Kinase 3; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Myofibroblasts; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Signal Transduction; STAT6 Transcription Factor; Ureteral Obstruction | 2015 |
Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases.
Topics: Animals; Atorvastatin; Chronic Disease; Fibrosis; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Tubules; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2009 |
Atorvastatin protects renal function in the rat with acute unilateral ureteral obstruction.
Topics: Acute Disease; Albuminuria; Animals; Atorvastatin; Hemodynamics; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2010 |
Atorvastatin ameliorates tissue damage of obstructed ureter in rats.
Topics: Animals; Apoptosis; Atorvastatin; Cytokines; Female; Fibrosis; Heptanoic Acids; Hydronephrosis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; In Situ Nick-End Labeling; Muscle, Smooth; Proliferating Cell Nuclear Antigen; Pyrroles; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ureter; Ureteral Obstruction | 2011 |
Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction.
Topics: Animals; Cell Line; Disease Models, Animal; Fibroblasts; Fibrosis; Humans; Kidney Tubules; Lymphangiogenesis; Macrophages; Male; Membrane Glycoproteins; Mice; Protein Serine-Threonine Kinases; Pyrazoles; Pyrroles; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Receptor, Transforming Growth Factor-beta Type I; Receptors, Cell Surface; Receptors, Transforming Growth Factor beta; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors; Transforming Growth Factor beta1; Up-Regulation; Ureteral Obstruction; Vascular Endothelial Growth Factor C | 2012 |
Atorvastatin prevents the downregulation of aquaporin-2 receptor after bilateral ureteral obstruction and protects renal function in a rat model.
Topics: Animals; Aquaporin 2; Atorvastatin; Down-Regulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Pyrroles; Rats; Rats, Wistar; Ureteral Obstruction | 2012 |
Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction.
Topics: Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Diseases; Pyrroles; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Ureteral Obstruction | 2004 |
Atorvastatin preserves renal function in chronic complete unilateral ureteral obstruction.
Topics: Animals; Atorvastatin; Chronic Disease; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Function Tests; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2007 |
[Effects of atorvastatin on expression of peroxisome proliferation activated receptor gamma in unilateral ureteral obstruction in rats].
Topics: Animals; Atorvastatin; Disease Models, Animal; Female; Heptanoic Acids; Kidney Tubules; Nephrosclerosis; PPAR gamma; Pyrroles; Random Allocation; Rats; Rats, Sprague-Dawley; Ureteral Obstruction | 2007 |
Metastatic renal cell carcinoma with partial response to sunitinib complicated by ureteral obstruction from necrotic tumor.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Kidney Pelvis; Liver Neoplasms; Middle Aged; Necrosis; Pyrroles; Sunitinib; Ureteral Obstruction | 2009 |
New drugs for renal colic therapy--in-vitro and animal experiments.
Topics: Acute Disease; Animals; Benzopyrans; Colic; Cromakalim; Dogs; Drug Evaluation, Preclinical; Female; Isometric Contraction; Kidney Calculi; Kidney Pelvis; Manometry; Muscle, Smooth; Potassium Channels; Pyrroles; Ureter; Ureteral Obstruction; Urodynamics | 1994 |